A new study argues for a revised clonal evolution model of cancer, incorporating genetic and non-genetic factors to improve understanding and treatment. Like all living organisms, cancer cells are ...

This 'cancer protection' gene could actually raise your risk of breast and ovarian cancer—here’s what you need to know ...

BARCELONA, Spain — In a groundbreaking study that could reshape our understanding of cancer, scientists have uncovered a treasure trove of potential new targets for cancer treatment. This discovery ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

To date, more than 600 genes are known to cause tumors when their sequences are spoiled by a mutation. Yet there are other ...

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumor cell growth, HER2. Despite this common trait, the development of ...

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

Neoadjuvant platinum-based chemotherapy improves structure preservation (SP) for patients with T3, T4a, and selected T4b ...

Scientists have demonstrated a new potential treatment for bone cancer. A bioactive glass laced with a toxic metal was able ...

Researchers investigated RA51C and uncovered over 3,000 harmful genetic changes that could increase cancer risk.

Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University, in collaboration with the ...

A $5.3 million National Institutes of Health grant awarded to the University of Oklahoma Health Sciences will support advanced cancer research in Oklahoma. The Centers of Biomedical Research ...